Russell Investments Group, Ltd. Vivos Therapeutics, Inc. Transaction History

Russell Investments Group, Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	SELL	$0.83 - $21.25 $37,921 - $970,870	-45,688 Reduced 11.1%	365,901 $236,000
Q2 2022 Jul 29, 2022	SELL	$1.12 - $2.18 $14,797 - $28,802	-13,212 Reduced 3.11%	411,589 $530,000
Q1 2022 May 05, 2022	BUY	$1.63 - $3.63 $195,119 - $434,529	119,705 Added 39.24%	424,801 $1.14 Million
Q4 2021 Jan 21, 2022	BUY	$2.25 - $4.11 $581,501 - $1.06 Million	258,445 Added 554.0%	305,096 $684,000
Q3 2021 Nov 08, 2021	BUY	$2.71 - $5.9 $126,424 - $275,240	46,651 New	46,651 $188,000

Ticker VVOS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 23,012,100
Market Cap $60.3M
Description
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dent...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.